Literature DB >> 34128487

Nonstigmatizing and Precise Terminology to Describe Processes and Outcomes in Addiction Medicine.

Rory A Pfund1, Samuel C Peter, Joshua K Swift, Katie Witkiewitz.   

Abstract

ABSTRACT: Scholarly journals and professional organizations in addiction medicine have recently discussed the importance of adopting nonstigmatizing and precise terminology. The present commentary expands that ongoing discussion to terms related to treatment processes and outcomes. Four implicit assumptions of stigmatizing and imprecise terms related to treatment processes and outcomes are overviewed, and research evidence against these assumptions is presented. The commentary ends with recommendations for the use of positive behavioral indicators of processes and outcomes and, more importantly, accompanying them with nonevaluative, objective descriptors of patients' behaviors.
Copyright © 2021 American Society of Addiction Medicine.

Entities:  

Mesh:

Year:  2022        PMID: 34128487      PMCID: PMC8669030          DOI: 10.1097/ADM.0000000000000885

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   4.647


  13 in total

1.  Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Emily Cohen; Richard Feinn; Albert Arias; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2006-08-17       Impact factor: 4.492

2.  Recommended Use of Terminology in Addiction Medicine.

Authors:  Richard Saitz; Shannon C Miller; David A Fiellin; Richard N Rosenthal
Journal:  J Addict Med       Date:  2021 Jan-Feb 01       Impact factor: 3.702

3.  When Does Premature Treatment Termination Occur? Examining Session-by-Session Dropout Among Clients with Gambling Disorder.

Authors:  Rory A Pfund; Samuel C Peter; James P Whelan; Andrew W Meyers
Journal:  J Gambl Stud       Date:  2018-06

4.  Is low therapist empathy toxic?

Authors:  Theresa B Moyers; William R Miller
Journal:  Psychol Addict Behav       Date:  2012-10-01

5.  Dropout from face-to-face, multi-session psychological treatments for problem and disordered gambling: A systematic review and meta-analysis.

Authors:  Rory A Pfund; Samuel C Peter; Nicholas W McAfee; Meredith K Ginley; James P Whelan; Andrew W Meyers
Journal:  Psychol Addict Behav       Date:  2021-04-22

6.  Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.

Authors:  Olivia Randall-Kosich; Barbara Andraka-Christou; Rachel Totaram; Jessica Alamo; Mayur Nadig
Journal:  J Addict Med       Date:  2020 Jul/Aug       Impact factor: 3.702

7.  Barriers to retention in substance use treatment: Validation of a new, theory-based scale.

Authors:  Sarah E Zemore; Orrin D Ware; Paul A Gilbert; Miguel Pinedo
Journal:  J Subst Abuse Treat       Date:  2021-04-21

Review 8.  Patient Preferences and Shared Decision Making in the Treatment of Substance Use Disorders: A Systematic Review of the Literature.

Authors:  Anke Friedrichs; Maren Spies; Martin Härter; Angela Buchholz
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

9.  Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment.

Authors:  Kirsten Marchand; Julie Foreman; Scott MacDonald; Scott Harrison; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-01-20
View more
  2 in total

1.  From Underground to Mainstream: Establishing a Medical Lexicon for Psychedelic Therapy.

Authors:  Andrew Beswerchij; Dominic Sisti
Journal:  Front Psychiatry       Date:  2022-06-17       Impact factor: 5.435

2.  Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications.

Authors:  Micah Hartwell; Vanessa Lin; Mackenzee Hester; Nicholas B Sajjadi; Kelly Dunn; James Morris; Katie Witkiewitz
Journal:  J Addict Med       Date:  2022-04-22       Impact factor: 4.647

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.